Getein Biotech, Inc (603387.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 4.24B |
| Enterprise Value | 4.41B |
| P/E Ratio | 15.41 |
| PEG Ratio | 0.17 |
| Price/Sales Ratio | 4.21 |
| Price/Book Ratio | 1.57 |
| Enterprise/Revenue | 4.19 |
| Enterprise/EBITDA | 13.8 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.27 |
| Operating Margin | 0.22 |
AD
Management Effectiveness
| Return On Assets | 0.08 |
| Return On Equity | 0.11 |
Income Statement
| Revenue | 1.04B |
| Revenue/Share | 2.16 |
| Gross Profit | 658.97M |
| EBITDA | 329.57M |
| Net Income | 220.66M |
| Diluted EPS | 0.44 |
Balance Sheet
| Total Cash | 1.68B |
| Total Cash/Share | 3.31 |
| Total Debt | 341.44M |
| Total Debt/Equity | 0.12 |
| Current Ratio | 3.76 |
| Book Value Per Share | 6.03 |
Price History
| 52-Week Change | 6.69 |
| 52-Week High | 11.42 |
| 52-Week Low | 7.37 |
| Moving Average 50 Days | 9 |
| Moving Average 200 Days | 8.89 |
Statistics
| Average Volume | 11.2M |
| Shares Outstanding | 507.15M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.24 |
| Trailing Annual Dividend Yield | 2.64 |
| Payout Ratio | 0.58 |
| Last Split Factor | 7:5 |
| Last Split Date | June 08, 2022 |
AD
